Xagenic
Company

Last deal

$11.8M
Local Amount - CAD 15M

Amount

Series B

Stage

09.07.2015

Date

7

all rounds

$60.1M

Total amount

General

About Company
Xagenic Inc. is a Toronto-based molecular diagnostics company developing decentralized, rapid diagnostic testing technology.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2010

Operating Status

Closed

Number of employees

Company Type

For Profit

Last funding type

Series B

IPO status

Private

Description

Xagenic is commercializing a fully automated platform for decentralized diagnostic testing outside of clinical laboratories. Their technology enables on-demand, near-patient molecular testing, empowering clinicians to make treatment decisions during the first consultation. By providing rapid test results, Xagenic aims to improve patient care and reduce healthcare costs. They are currently developing infectious disease tests that can detect various analytes, further enhancing the clinical usefulness of their platform.
Contacts